Use of disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) was markedly lower among all major racial-ethnic minority groups in the U.S. compared with white patients, analysis ...

Please provide your email address to receive an email when new articles are posted on . Nearly all bDMARDs and tsDMARDs feature infection or malignancy warnings from the FDA or European Medicines ...

While overall risks for adverse birth outcomes were not increased in children born to fathers who used disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, for autoimmune diseases in ...

Immunosuppressants are a class of medications that inhibit or decrease immune system activity. They can help treat certain autoimmune conditions or reduce the risk of the body rejecting an organ or ...

Nonadherence to DMARDs in RA varies widely, with rates from 1.5% to 100% across different studies and DMARD classes. The review identified 31 unique nonadherence measures, with indirect methods like ...